These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22805424)

  • 21. Noncompliance with NASPGHAN-ESPGHAN practice guidelines for GER in Europe: is there a point?
    Thaler MM
    J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):396-7. PubMed ID: 24795982
    [No Abstract]   [Full Text] [Related]  

  • 22. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.
    Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N
    Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitor administration in neonates and infants. Lack of consensus - An ASPO survey.
    Zoizner-Agar G; Rotsides JM; Shao Q; Rickert S; Ward R; Greifer M; April M
    Int J Pediatr Otorhinolaryngol; 2020 Oct; 137():110200. PubMed ID: 32679431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children.
    Baird DC; Harker DJ; Karmes AS
    Am Fam Physician; 2015 Oct; 92(8):705-14. PubMed ID: 26554410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pantoprazole for symptoms of infant GERD: the emperor has no clothes!
    Orenstein SR; Hassall E
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):537; author reply 537-9. PubMed ID: 20871256
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory gastroesophageal reflux disease.
    Moraes-Filho JP
    Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infant GERD: symptoms, reflux episodes & reflux disease, acid & non-acid refllux--implications for treatment with PPIs.
    Orenstein SR
    Curr Gastroenterol Rep; 2013 Nov; 15(11):353. PubMed ID: 24197743
    [No Abstract]   [Full Text] [Related]  

  • 28. Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior.
    Lacy BE; Crowell MD; Riesett RP; Mitchell A
    J Clin Gastroenterol; 2005 Jul; 39(6):489-94. PubMed ID: 15942434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed?
    Çelebi A; Yılmaz H
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S71-S72. PubMed ID: 29199173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of delayed release rabeprazole in 1- to 11-month-old infants with symptomatic GERD.
    Hussain S; Kierkus J; Hu P; Hoffman D; Lekich R; Sloan S; Treem W
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):226-36. PubMed ID: 24121146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy.
    Colletti RB; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S7-S11. PubMed ID: 14685071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey on the Adherence to the 2009 NASPGHAN-ESPGHAN Gastroesophageal Reflux Guidelines by Brazilian Paediatricians.
    Vieira SCF; Gurgel FM; Leão MZ; Costa-Silva TE; Barreto IDC; Martins-Filho PRS; Vieira MC; Gurgel RQ
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):e1-e5. PubMed ID: 29394212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing the use of proton pump inhibitors in infants with reflux symptoms.
    Størdal K; Ma A; Beck CE
    BMJ; 2024 May; 385():e074588. PubMed ID: 38816024
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the GERD Impact Scale, an international, validated patient questionnaire, in daily practice. Results of the ALEGRIA study.
    Louis E; Tack J; Vandenhoven G; Taeter C
    Acta Gastroenterol Belg; 2009; 72(1):3-8. PubMed ID: 19402364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omeprazole-induced cough in a patient with gastroesophageal reflux disease.
    Reiche I; Tröger U; Martens-Lobenhoffer J; Kandulski A; Neumann H; Malfertheiner P; Bode-Böger SM
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):880-2. PubMed ID: 19801940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.
    Romano C; Chiaro A; Comito D; Loddo I; Ferrau V
    Curr Clin Pharmacol; 2011 Feb; 6(1):41-7. PubMed ID: 21235462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
    Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
    J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
    Solem C; Mody R; Stephens J; Macahilig C; Gao X
    J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A posseting infant].
    Merras-Salmio L; Kolho KL
    Duodecim; 2015; 131(3):262-9. PubMed ID: 26245077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.